Characterization of preparations of GAD65, proinsulin, and the islet tyrosine phosphatase IA-2 for use in detection of Autoreactive T-cells in type 1 Diabetes report of phase II of the second international Immunology of Diabetes Society workshop for standardization of T-cell assays in type 1 Diabetes

The identification, quantification, and characterization of T-cells reactive with the islet autoantigens GAD65, proinsulin (PI), and tyrosine phosphatase-like molecules IA-2 and phogrin are major research goals in type 1 diabetes. In the Immunology of Diabetes Society First Workshop on Autoreactive...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Diabetes (New York, N.Y.) N.Y.), 2001-08, Vol.50 (8), p.1749-1754
Hauptverfasser: PEAKMAN, Mark, TREE, Timothy I, ENDL, Josef, VAN ENDERT, Peter, ATKINSON, Mark A, ROEP, Bart O
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 1754
container_issue 8
container_start_page 1749
container_title Diabetes (New York, N.Y.)
container_volume 50
creator PEAKMAN, Mark
TREE, Timothy I
ENDL, Josef
VAN ENDERT, Peter
ATKINSON, Mark A
ROEP, Bart O
description The identification, quantification, and characterization of T-cells reactive with the islet autoantigens GAD65, proinsulin (PI), and tyrosine phosphatase-like molecules IA-2 and phogrin are major research goals in type 1 diabetes. In the Immunology of Diabetes Society First Workshop on Autoreactive T-Cells, the quality of recombinant preparations of these autoantigens was identified as a significant weakness, a finding that may account for much of the inconsistency in published studies of peripheral blood T-cell reactivity to islet autoantigens. Poor antigen quality has also hampered the development of novel technologies for the detection of islet-reactive T-cells. For these reasons, in the present study, several preparations of GAD65, PI, and IA-2 were collected and evaluated for endotoxin content, ability to stimulate a panel of relevant T-cell clones, and inhibitory effects on proliferation to unrelated third-party antigens. Through this process, we have been able to identify preparations of GAD65 and IA-2, generated in insect cells using the baculovirus expression system, that stimulate relevant clones and display low inhibitory effects on third-party antigens. In addition, we characterized a PI preparation generated in bacteria as being free of effects on proliferation to third-party antigens and low in endotoxin content. These preparations are important to promote the development of robust and sensitive assays of islet-reactive T-cells in patients with type 1 diabetes or patients at high risk for developing the disease.
doi_str_mv 10.2337/diabetes.50.8.1749
format Article
fullrecord <record><control><sourceid>gale_proqu</sourceid><recordid>TN_cdi_proquest_miscellaneous_71038725</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><galeid>A80392873</galeid><sourcerecordid>A80392873</sourcerecordid><originalsourceid>FETCH-LOGICAL-g409t-5ca69b4305bcdab5202f134a977f0b28fba602b7d544c6fdb57b69b9b7ee914c3</originalsourceid><addsrcrecordid>eNptklGPlDAQgNFovPX0D_hgGhOND8taKFB43Ozpuskm9-CZ-EZKGaBnabEtKv56y-6eembThzKTj5lvBoLgRYRXMSH0XS1YBQ7sKsWrfBXRpHgYLKKCFCGJ6ZdHwQLjKA4jWtCL4Km1txjjzJ8nwUUUJZRgkiwehJuOGcYdGPGLOaEV0g0aDAw-O4d2jrfrqyxd-rQWyo5SqCViqkauAySsBIfcZLQVCtDQaTt0zDELaLcOY9Rog0YfCIVq78rvWqxHpw34xuI7oJuQg5R2htw0AIrQ1Wk05E20cQep7lB0Nz_PnS1w7SWE8u7q4Mok2vX9qLTU7TRjf6p80lyAm9APbb7aTg8HLev8EMzU_wx-FEHMWjad03kWPG6YtPD8dF8Gnz-8v9l8DPfX291mvQ_bBBcuTDnLiiohOK14zao0xnETkYQVlDa4ivOmYhmOK1qnScKzpq5SWvkXiooCFFHCyWXw5ljXr_zbCNaVvbCzGlOgR1vSCJOcxqkHX_0H3urRr0PaMo6yJKMkzz20PEItk1AK1WjnP3kLCgyTWkEjfHqdY1LEOSUeD8_g_tTQC36Of3uP94iDn65lo7Vlvt3fQ5fnUK6lhBZKv8PN9T385Wm6seqhLgcjemam8u739cDrE8AsZ7IxTHFh_3IJzkkW5-Q31skDcg</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>216467388</pqid></control><display><type>article</type><title>Characterization of preparations of GAD65, proinsulin, and the islet tyrosine phosphatase IA-2 for use in detection of Autoreactive T-cells in type 1 Diabetes report of phase II of the second international Immunology of Diabetes Society workshop for standardization of T-cell assays in type 1 Diabetes</title><source>MEDLINE</source><source>EZB-FREE-00999 freely available EZB journals</source><creator>PEAKMAN, Mark ; TREE, Timothy I ; ENDL, Josef ; VAN ENDERT, Peter ; ATKINSON, Mark A ; ROEP, Bart O</creator><creatorcontrib>PEAKMAN, Mark ; TREE, Timothy I ; ENDL, Josef ; VAN ENDERT, Peter ; ATKINSON, Mark A ; ROEP, Bart O ; Second International Immunology of Diabetes Society Workshop for Standardization ot T-cell Assays in Type 1 Diabetes</creatorcontrib><description>The identification, quantification, and characterization of T-cells reactive with the islet autoantigens GAD65, proinsulin (PI), and tyrosine phosphatase-like molecules IA-2 and phogrin are major research goals in type 1 diabetes. In the Immunology of Diabetes Society First Workshop on Autoreactive T-Cells, the quality of recombinant preparations of these autoantigens was identified as a significant weakness, a finding that may account for much of the inconsistency in published studies of peripheral blood T-cell reactivity to islet autoantigens. Poor antigen quality has also hampered the development of novel technologies for the detection of islet-reactive T-cells. For these reasons, in the present study, several preparations of GAD65, PI, and IA-2 were collected and evaluated for endotoxin content, ability to stimulate a panel of relevant T-cell clones, and inhibitory effects on proliferation to unrelated third-party antigens. Through this process, we have been able to identify preparations of GAD65 and IA-2, generated in insect cells using the baculovirus expression system, that stimulate relevant clones and display low inhibitory effects on third-party antigens. In addition, we characterized a PI preparation generated in bacteria as being free of effects on proliferation to third-party antigens and low in endotoxin content. These preparations are important to promote the development of robust and sensitive assays of islet-reactive T-cells in patients with type 1 diabetes or patients at high risk for developing the disease.</description><identifier>ISSN: 0012-1797</identifier><identifier>EISSN: 1939-327X</identifier><identifier>DOI: 10.2337/diabetes.50.8.1749</identifier><identifier>PMID: 11473034</identifier><identifier>CODEN: DIAEAZ</identifier><language>eng</language><publisher>Alexandria, VA: American Diabetes Association</publisher><subject>Animals ; Antigens ; Autoantigens - immunology ; Baculoviridae ; Biological and medical sciences ; Cell Line ; Clone Cells ; Cloning ; Diabetes ; Diabetes Mellitus, Type 1 - diagnosis ; Diabetes Mellitus, Type 1 - immunology ; Diabetes research ; Diabetes. Impaired glucose tolerance ; Endocrine pancreas. Apud cells (diseases) ; Endocrinopathies ; Endotoxins - immunology ; Glutamate Decarboxylase - immunology ; Humans ; Immunology ; Insulin ; Insulin - immunology ; Insulin - pharmacology ; Islets of Langerhans - immunology ; Isoenzymes - immunology ; Lymphocyte Activation - drug effects ; Management. Various non-drug treatments. Langerhans islet grafts ; Medical sciences ; Phosphatase ; Proinsulin - immunology ; Protein Tyrosine Phosphatase, Non-Receptor Type 1 ; Protein Tyrosine Phosphatases - immunology ; Receptor-Like Protein Tyrosine Phosphatases, Class 8 ; Recombinant Proteins - immunology ; Risk Factors ; Sensitivity and Specificity ; Spodoptera ; T-Lymphocytes - drug effects ; T-Lymphocytes - immunology ; Tetanus Toxoid - immunology ; Third party ; Transfection</subject><ispartof>Diabetes (New York, N.Y.), 2001-08, Vol.50 (8), p.1749-1754</ispartof><rights>2002 INIST-CNRS</rights><rights>COPYRIGHT 2001 American Diabetes Association</rights><rights>Copyright American Diabetes Association Aug 2001</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,776,780,27901,27902</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&amp;idt=14083628$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/11473034$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>PEAKMAN, Mark</creatorcontrib><creatorcontrib>TREE, Timothy I</creatorcontrib><creatorcontrib>ENDL, Josef</creatorcontrib><creatorcontrib>VAN ENDERT, Peter</creatorcontrib><creatorcontrib>ATKINSON, Mark A</creatorcontrib><creatorcontrib>ROEP, Bart O</creatorcontrib><creatorcontrib>Second International Immunology of Diabetes Society Workshop for Standardization ot T-cell Assays in Type 1 Diabetes</creatorcontrib><title>Characterization of preparations of GAD65, proinsulin, and the islet tyrosine phosphatase IA-2 for use in detection of Autoreactive T-cells in type 1 Diabetes report of phase II of the second international Immunology of Diabetes Society workshop for standardization of T-cell assays in type 1 Diabetes</title><title>Diabetes (New York, N.Y.)</title><addtitle>Diabetes</addtitle><description>The identification, quantification, and characterization of T-cells reactive with the islet autoantigens GAD65, proinsulin (PI), and tyrosine phosphatase-like molecules IA-2 and phogrin are major research goals in type 1 diabetes. In the Immunology of Diabetes Society First Workshop on Autoreactive T-Cells, the quality of recombinant preparations of these autoantigens was identified as a significant weakness, a finding that may account for much of the inconsistency in published studies of peripheral blood T-cell reactivity to islet autoantigens. Poor antigen quality has also hampered the development of novel technologies for the detection of islet-reactive T-cells. For these reasons, in the present study, several preparations of GAD65, PI, and IA-2 were collected and evaluated for endotoxin content, ability to stimulate a panel of relevant T-cell clones, and inhibitory effects on proliferation to unrelated third-party antigens. Through this process, we have been able to identify preparations of GAD65 and IA-2, generated in insect cells using the baculovirus expression system, that stimulate relevant clones and display low inhibitory effects on third-party antigens. In addition, we characterized a PI preparation generated in bacteria as being free of effects on proliferation to third-party antigens and low in endotoxin content. These preparations are important to promote the development of robust and sensitive assays of islet-reactive T-cells in patients with type 1 diabetes or patients at high risk for developing the disease.</description><subject>Animals</subject><subject>Antigens</subject><subject>Autoantigens - immunology</subject><subject>Baculoviridae</subject><subject>Biological and medical sciences</subject><subject>Cell Line</subject><subject>Clone Cells</subject><subject>Cloning</subject><subject>Diabetes</subject><subject>Diabetes Mellitus, Type 1 - diagnosis</subject><subject>Diabetes Mellitus, Type 1 - immunology</subject><subject>Diabetes research</subject><subject>Diabetes. Impaired glucose tolerance</subject><subject>Endocrine pancreas. Apud cells (diseases)</subject><subject>Endocrinopathies</subject><subject>Endotoxins - immunology</subject><subject>Glutamate Decarboxylase - immunology</subject><subject>Humans</subject><subject>Immunology</subject><subject>Insulin</subject><subject>Insulin - immunology</subject><subject>Insulin - pharmacology</subject><subject>Islets of Langerhans - immunology</subject><subject>Isoenzymes - immunology</subject><subject>Lymphocyte Activation - drug effects</subject><subject>Management. Various non-drug treatments. Langerhans islet grafts</subject><subject>Medical sciences</subject><subject>Phosphatase</subject><subject>Proinsulin - immunology</subject><subject>Protein Tyrosine Phosphatase, Non-Receptor Type 1</subject><subject>Protein Tyrosine Phosphatases - immunology</subject><subject>Receptor-Like Protein Tyrosine Phosphatases, Class 8</subject><subject>Recombinant Proteins - immunology</subject><subject>Risk Factors</subject><subject>Sensitivity and Specificity</subject><subject>Spodoptera</subject><subject>T-Lymphocytes - drug effects</subject><subject>T-Lymphocytes - immunology</subject><subject>Tetanus Toxoid - immunology</subject><subject>Third party</subject><subject>Transfection</subject><issn>0012-1797</issn><issn>1939-327X</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2001</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><sourceid>8G5</sourceid><sourceid>BEC</sourceid><sourceid>BENPR</sourceid><sourceid>GUQSH</sourceid><sourceid>M2O</sourceid><recordid>eNptklGPlDAQgNFovPX0D_hgGhOND8taKFB43Ozpuskm9-CZ-EZKGaBnabEtKv56y-6eembThzKTj5lvBoLgRYRXMSH0XS1YBQ7sKsWrfBXRpHgYLKKCFCGJ6ZdHwQLjKA4jWtCL4Km1txjjzJ8nwUUUJZRgkiwehJuOGcYdGPGLOaEV0g0aDAw-O4d2jrfrqyxd-rQWyo5SqCViqkauAySsBIfcZLQVCtDQaTt0zDELaLcOY9Rog0YfCIVq78rvWqxHpw34xuI7oJuQg5R2htw0AIrQ1Wk05E20cQep7lB0Nz_PnS1w7SWE8u7q4Mok2vX9qLTU7TRjf6p80lyAm9APbb7aTg8HLev8EMzU_wx-FEHMWjad03kWPG6YtPD8dF8Gnz-8v9l8DPfX291mvQ_bBBcuTDnLiiohOK14zao0xnETkYQVlDa4ivOmYhmOK1qnScKzpq5SWvkXiooCFFHCyWXw5ljXr_zbCNaVvbCzGlOgR1vSCJOcxqkHX_0H3urRr0PaMo6yJKMkzz20PEItk1AK1WjnP3kLCgyTWkEjfHqdY1LEOSUeD8_g_tTQC36Of3uP94iDn65lo7Vlvt3fQ5fnUK6lhBZKv8PN9T385Wm6seqhLgcjemam8u739cDrE8AsZ7IxTHFh_3IJzkkW5-Q31skDcg</recordid><startdate>20010801</startdate><enddate>20010801</enddate><creator>PEAKMAN, Mark</creator><creator>TREE, Timothy I</creator><creator>ENDL, Josef</creator><creator>VAN ENDERT, Peter</creator><creator>ATKINSON, Mark A</creator><creator>ROEP, Bart O</creator><general>American Diabetes Association</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>8GL</scope><scope>3V.</scope><scope>7RV</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>88I</scope><scope>8AF</scope><scope>8AO</scope><scope>8C1</scope><scope>8FE</scope><scope>8FH</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>8G5</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BBNVY</scope><scope>BEC</scope><scope>BENPR</scope><scope>BHPHI</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>GUQSH</scope><scope>HCIFZ</scope><scope>K9-</scope><scope>K9.</scope><scope>KB0</scope><scope>LK8</scope><scope>M0R</scope><scope>M0S</scope><scope>M1P</scope><scope>M2O</scope><scope>M2P</scope><scope>M7P</scope><scope>MBDVC</scope><scope>NAPCQ</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>Q9U</scope><scope>S0X</scope><scope>7X8</scope></search><sort><creationdate>20010801</creationdate><title>Characterization of preparations of GAD65, proinsulin, and the islet tyrosine phosphatase IA-2 for use in detection of Autoreactive T-cells in type 1 Diabetes report of phase II of the second international Immunology of Diabetes Society workshop for standardization of T-cell assays in type 1 Diabetes</title><author>PEAKMAN, Mark ; TREE, Timothy I ; ENDL, Josef ; VAN ENDERT, Peter ; ATKINSON, Mark A ; ROEP, Bart O</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-g409t-5ca69b4305bcdab5202f134a977f0b28fba602b7d544c6fdb57b69b9b7ee914c3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2001</creationdate><topic>Animals</topic><topic>Antigens</topic><topic>Autoantigens - immunology</topic><topic>Baculoviridae</topic><topic>Biological and medical sciences</topic><topic>Cell Line</topic><topic>Clone Cells</topic><topic>Cloning</topic><topic>Diabetes</topic><topic>Diabetes Mellitus, Type 1 - diagnosis</topic><topic>Diabetes Mellitus, Type 1 - immunology</topic><topic>Diabetes research</topic><topic>Diabetes. Impaired glucose tolerance</topic><topic>Endocrine pancreas. Apud cells (diseases)</topic><topic>Endocrinopathies</topic><topic>Endotoxins - immunology</topic><topic>Glutamate Decarboxylase - immunology</topic><topic>Humans</topic><topic>Immunology</topic><topic>Insulin</topic><topic>Insulin - immunology</topic><topic>Insulin - pharmacology</topic><topic>Islets of Langerhans - immunology</topic><topic>Isoenzymes - immunology</topic><topic>Lymphocyte Activation - drug effects</topic><topic>Management. Various non-drug treatments. Langerhans islet grafts</topic><topic>Medical sciences</topic><topic>Phosphatase</topic><topic>Proinsulin - immunology</topic><topic>Protein Tyrosine Phosphatase, Non-Receptor Type 1</topic><topic>Protein Tyrosine Phosphatases - immunology</topic><topic>Receptor-Like Protein Tyrosine Phosphatases, Class 8</topic><topic>Recombinant Proteins - immunology</topic><topic>Risk Factors</topic><topic>Sensitivity and Specificity</topic><topic>Spodoptera</topic><topic>T-Lymphocytes - drug effects</topic><topic>T-Lymphocytes - immunology</topic><topic>Tetanus Toxoid - immunology</topic><topic>Third party</topic><topic>Transfection</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>PEAKMAN, Mark</creatorcontrib><creatorcontrib>TREE, Timothy I</creatorcontrib><creatorcontrib>ENDL, Josef</creatorcontrib><creatorcontrib>VAN ENDERT, Peter</creatorcontrib><creatorcontrib>ATKINSON, Mark A</creatorcontrib><creatorcontrib>ROEP, Bart O</creatorcontrib><creatorcontrib>Second International Immunology of Diabetes Society Workshop for Standardization ot T-cell Assays in Type 1 Diabetes</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>Gale In Context: High School</collection><collection>ProQuest Central (Corporate)</collection><collection>Nursing &amp; Allied Health Database</collection><collection>Health &amp; Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>Science Database (Alumni Edition)</collection><collection>STEM Database</collection><collection>ProQuest Pharma Collection</collection><collection>Public Health Database</collection><collection>ProQuest SciTech Collection</collection><collection>ProQuest Natural Science Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>Research Library (Alumni Edition)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central Essentials</collection><collection>Biological Science Collection</collection><collection>eLibrary</collection><collection>ProQuest Central</collection><collection>Natural Science Collection</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central Korea</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>Research Library Prep</collection><collection>SciTech Premium Collection</collection><collection>Consumer Health Database (Alumni Edition)</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Nursing &amp; Allied Health Database (Alumni Edition)</collection><collection>ProQuest Biological Science Collection</collection><collection>Consumer Health Database</collection><collection>Health &amp; Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>Research Library</collection><collection>Science Database</collection><collection>Biological Science Database</collection><collection>Research Library (Corporate)</collection><collection>Nursing &amp; Allied Health Premium</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>ProQuest Central Basic</collection><collection>SIRS Editorial</collection><collection>MEDLINE - Academic</collection><jtitle>Diabetes (New York, N.Y.)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>PEAKMAN, Mark</au><au>TREE, Timothy I</au><au>ENDL, Josef</au><au>VAN ENDERT, Peter</au><au>ATKINSON, Mark A</au><au>ROEP, Bart O</au><aucorp>Second International Immunology of Diabetes Society Workshop for Standardization ot T-cell Assays in Type 1 Diabetes</aucorp><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Characterization of preparations of GAD65, proinsulin, and the islet tyrosine phosphatase IA-2 for use in detection of Autoreactive T-cells in type 1 Diabetes report of phase II of the second international Immunology of Diabetes Society workshop for standardization of T-cell assays in type 1 Diabetes</atitle><jtitle>Diabetes (New York, N.Y.)</jtitle><addtitle>Diabetes</addtitle><date>2001-08-01</date><risdate>2001</risdate><volume>50</volume><issue>8</issue><spage>1749</spage><epage>1754</epage><pages>1749-1754</pages><issn>0012-1797</issn><eissn>1939-327X</eissn><coden>DIAEAZ</coden><abstract>The identification, quantification, and characterization of T-cells reactive with the islet autoantigens GAD65, proinsulin (PI), and tyrosine phosphatase-like molecules IA-2 and phogrin are major research goals in type 1 diabetes. In the Immunology of Diabetes Society First Workshop on Autoreactive T-Cells, the quality of recombinant preparations of these autoantigens was identified as a significant weakness, a finding that may account for much of the inconsistency in published studies of peripheral blood T-cell reactivity to islet autoantigens. Poor antigen quality has also hampered the development of novel technologies for the detection of islet-reactive T-cells. For these reasons, in the present study, several preparations of GAD65, PI, and IA-2 were collected and evaluated for endotoxin content, ability to stimulate a panel of relevant T-cell clones, and inhibitory effects on proliferation to unrelated third-party antigens. Through this process, we have been able to identify preparations of GAD65 and IA-2, generated in insect cells using the baculovirus expression system, that stimulate relevant clones and display low inhibitory effects on third-party antigens. In addition, we characterized a PI preparation generated in bacteria as being free of effects on proliferation to third-party antigens and low in endotoxin content. These preparations are important to promote the development of robust and sensitive assays of islet-reactive T-cells in patients with type 1 diabetes or patients at high risk for developing the disease.</abstract><cop>Alexandria, VA</cop><pub>American Diabetes Association</pub><pmid>11473034</pmid><doi>10.2337/diabetes.50.8.1749</doi><tpages>6</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0012-1797
ispartof Diabetes (New York, N.Y.), 2001-08, Vol.50 (8), p.1749-1754
issn 0012-1797
1939-327X
language eng
recordid cdi_proquest_miscellaneous_71038725
source MEDLINE; EZB-FREE-00999 freely available EZB journals
subjects Animals
Antigens
Autoantigens - immunology
Baculoviridae
Biological and medical sciences
Cell Line
Clone Cells
Cloning
Diabetes
Diabetes Mellitus, Type 1 - diagnosis
Diabetes Mellitus, Type 1 - immunology
Diabetes research
Diabetes. Impaired glucose tolerance
Endocrine pancreas. Apud cells (diseases)
Endocrinopathies
Endotoxins - immunology
Glutamate Decarboxylase - immunology
Humans
Immunology
Insulin
Insulin - immunology
Insulin - pharmacology
Islets of Langerhans - immunology
Isoenzymes - immunology
Lymphocyte Activation - drug effects
Management. Various non-drug treatments. Langerhans islet grafts
Medical sciences
Phosphatase
Proinsulin - immunology
Protein Tyrosine Phosphatase, Non-Receptor Type 1
Protein Tyrosine Phosphatases - immunology
Receptor-Like Protein Tyrosine Phosphatases, Class 8
Recombinant Proteins - immunology
Risk Factors
Sensitivity and Specificity
Spodoptera
T-Lymphocytes - drug effects
T-Lymphocytes - immunology
Tetanus Toxoid - immunology
Third party
Transfection
title Characterization of preparations of GAD65, proinsulin, and the islet tyrosine phosphatase IA-2 for use in detection of Autoreactive T-cells in type 1 Diabetes report of phase II of the second international Immunology of Diabetes Society workshop for standardization of T-cell assays in type 1 Diabetes
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-05T08%3A33%3A25IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-gale_proqu&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Characterization%20of%20preparations%20of%20GAD65,%20proinsulin,%20and%20the%20islet%20tyrosine%20phosphatase%20IA-2%20for%20use%20in%20detection%20of%20Autoreactive%20T-cells%20in%20type%201%20Diabetes%20report%20of%20phase%20II%20of%20the%20second%20international%20Immunology%20of%20Diabetes%20Society%20workshop%20for%20standardization%20of%20T-cell%20assays%20in%20type%201%20Diabetes&rft.jtitle=Diabetes%20(New%20York,%20N.Y.)&rft.au=PEAKMAN,%20Mark&rft.aucorp=Second%20International%20Immunology%20of%20Diabetes%20Society%20Workshop%20for%20Standardization%20ot%20T-cell%20Assays%20in%20Type%201%20Diabetes&rft.date=2001-08-01&rft.volume=50&rft.issue=8&rft.spage=1749&rft.epage=1754&rft.pages=1749-1754&rft.issn=0012-1797&rft.eissn=1939-327X&rft.coden=DIAEAZ&rft_id=info:doi/10.2337/diabetes.50.8.1749&rft_dat=%3Cgale_proqu%3EA80392873%3C/gale_proqu%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=216467388&rft_id=info:pmid/11473034&rft_galeid=A80392873&rfr_iscdi=true